Literature DB >> 23590032

Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging.

Rungroj Krittayaphong1, Veerawat Nomsawadi, Muenpetch Muenkaew, Monsawan Miniphan, Ahthit Yindeengam, Suthipol Udompunturak.   

Abstract

BACKGROUND: There are many ECG criteria for the diagnosis of left ventricular hypertrophy (LVH). There are, however limited data on the accuracy of these criteria in comparison with cardiac magnetic resonance (CMR).
OBJECTIVE: To determine the accuracy of ECG criteria for the diagnosis of LVH using CMR as the gold standard and to assess gender-specific data. MATERIAL AND
METHOD: Patients who were referred for CMR for clinical purposes were studied. ECG and CMR were performed on the same day. Functional CMR protocol was performed for the assessment of cardiac volume, function and mass. CMR variables were indexed by the adjustment of body surface area. The following ECG criteria were used: Romhilt-Estes criteria (score at least 4 or 5 points were used in the present study), Sokolow-Lyon and Sokolow-Lyon-Rappaport, Cornell voltage and Cornell product, and sum of QRS voltage of all 12 leads. CMR of 184 subjects (120females, 64 males) free of cardiovascular disease was used as controls. Patients with left ventricular mass index above 95 percentile of gender specific left ventricular mass in control group were considered LVH. Diagnostic yield of ECG criteria for LVH was calculated for the whole group and each gender
RESULTS: There were a total of 1,882 patients, 994 males and 888 females. Average age was 64.6 +/- 11.3 years. LVH was diagnosed by CMR in 23.3% in female and 25.4% in male. ECG criteria for the diagnosis of LVH had a relatively low sensitivity (0.25-0.61), and high specificity (0.75-0.95). Female had a lower sensitivity, higher specificity, higher PPV similar NPV and higher overall accuracy than male. Cornell product, Romhilt-Estes (at least 4 points) and Sokolow-Lyon were the ECG criteria with the best accuracy, sensitivity and specificity, respectively.
CONCLUSION: ECG criteria for the diagnosis of LVH had a relatively low sensitivity, and high specificity. The accuracy was in the range of 0.71-0.80. Cornell product had the highest accuracy.

Entities:  

Mesh:

Year:  2013        PMID: 23590032

Source DB:  PubMed          Journal:  J Med Assoc Thai        ISSN: 0125-2208


  5 in total

1.  Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.

Authors:  Veerawat Nomsawadi; Rungroj Krittayaphong
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-05       Impact factor: 1.468

2.  The effect of obesity on electrocardiographic detection of hypertensive left ventricular hypertrophy: recalibration against cardiac magnetic resonance.

Authors:  J C L Rodrigues; B McIntyre; A G Dastidar; S M Lyen; L E Ratcliffe; A E Burchell; E C Hart; C Bucciarelli-Ducci; M C K Hamilton; J F R Paton; A K Nightingale; N E Manghat
Journal:  J Hum Hypertens       Date:  2015-06-04       Impact factor: 3.012

3.  Prognostic significance of body mass index-adjusted criteria for left ventricular hypertrophy.

Authors:  Hesham Afify; Ho Lim Lee; Elsayed Z Soliman; Matthew J Singleton
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-08-06       Impact factor: 3.738

4.  Clinical applicability and diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy diagnosis in older adults.

Authors:  Caio de Assis Moura Tavares; Nelson Samesima; Ludhmila Abrahão Hajjar; Lucas C Godoy; Eduardo Messias Hirano Padrão; Felippe Lazar Neto; Mirella Facin; Wilson Jacob-Filho; Michael E Farkouh; Carlos Alberto Pastore
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

5.  Long-Term Impact of Different Triple Combination Antihypertensive Medications on Blood Pressure Control, Metabolic Pattern and Incident Events: Data from the Brisighella Heart Study.

Authors:  Arrigo F G Cicero; Federica Fogacci; Elisabetta Rizzoli; Sergio D'Addato; Claudio Borghi
Journal:  J Clin Med       Date:  2021-12-17       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.